Streetbeat News

Stock Prices

Zscaler (NASDAQ:ZS) has significantly outperformed the market, with an average annual return of 38.24% over the past 5 years. An investment of $100 in ZS stock 5 years ago would be worth $494.46 today. Zscaler's market capitalization currently stands at $29.78 billion.

Portfolio Pulse from Benzinga Insights

December 06, 2023 | 2:30 pm

ANGI

APTV

ARRY

BBWI

BMY

DAR

ENPH

FSLR

MRNA

PFE

SHLS

Goldman Sachs has identified S&P 500 laggards with potential for significant gains in 2024. These stocks have underperformed the market but are Buy-rated with upside potential. Categories include stocks with bullish views, defying consensus estimates, reasonable valuations, rebounding margins, and superior CROCI. Notable stocks include Moderna, Pfizer, Enphase Energy, Darling Ingredients, Shoals Technologies, ANGI Homeservices, Array Technologies, First Solar, Bath & Body Works, Sensata Technologies, Aptiv, and Bristol-Myers Squibb.

Portfolio Pulse from Piero Cingari

December 06, 2023 | 2:26 pm

CAMT

B. Riley Securities analyst Craig Ellis has upgraded Camtek (NASDAQ:CAMT) from Neutral to Buy and increased the price target from $70 to $75.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 2:25 pm

SPHR

Guggenheim analyst Ian Zaffino upgraded Sphere Entertainment (NYSE:SPHR) from Neutral to Buy and increased the price target from $38 to $40, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 2:23 pm

AAPL

ADPT

CORN

HOOD

NFLX

NVDA

QQQ

TSLA

UPS

Swaggy Stocks has identified the top 10 trending stocks on WallStreetBets as of December 6, 2023. The list includes NVDA, ADPT, TSLA, CORN, AAPL, NFLX, HOOD, AI, UPS, and the ETF QQQ.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 2:21 pm

OPTN

OptiNose, Inc. (NASDAQ:OPTN) stock plummeted after announcing a three-month delay in the FDA review of XHANCE for chronic rhinosinusitis. The new PDUFA goal date is March 16, 2024. The FDA requested additional analyses of clinical data, which OptiNose submitted, but the FDA needs more time to review. OPTN shares dropped 19.73% to $1.18 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

December 06, 2023 | 2:21 pm

IPA

ImmunoPrecise Antibodies Ltd. (IPA) shares have dropped following the announcement of a $1.1 million public offering of common shares. The offering is likely dilutive to existing shareholders, causing the stock price to decrease.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 2:18 pm

SERA

Sera Prognostics' stock price has risen following the recommendation by the DSMB to halt enrollment in its PRIME study due to efficacy, indicating positive results.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 2:17 pm

TER

Teradyne (NYSE:TER) has seen a decrease in short interest, with the short percent of float dropping 4.07% since the last report. The company has 3.80 million shares sold short, representing 2.83% of available shares. The average time to cover these short positions is 2.16 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Teradyne's short interest is below its peer group average of 6.84%.

Portfolio Pulse from Benzinga Insights

December 06, 2023 | 2:15 pm

SPCE

Virgin Galactic Holdings (NYSE:SPCE) has seen a 3.37% increase in short interest since the last report, with 76.48 million shares sold short, representing 20.85% of available shares. The short interest is higher than the peer group average of 8.67%. While high short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. It takes an average of 5.24 days for traders to cover their short positions.

Portfolio Pulse from Benzinga Insights

December 06, 2023 | 2:15 pm